RxDoctor Payments Data

Diane Steere, MD

Family Medicine · Wichita, KSNPI 1164483863

Payments from drug & device makers

$4,282in general payments, 2019–2025

Across 311 payments — averaging $13.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$772
  • Novo Nordisk$677
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$281
  • AbbVie$251
  • Pfizer$225
  • Amarin Pharma, Inc.$184
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$4,282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,282 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$150,292
Medicare patients
240
Services billed
5,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$76,141
EliquisApixaban39$41,958
JardianceEmpagliflozin30$36,882
TrulicityDulaglutide30$27,491
FarxigaDapagliflozin Propanediol21$18,761
JanuviaSitagliptin Phosphate21$15,754
MounjaroTirzepatide12$12,482
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$10,711
MyrbetriqMirabegron23$10,128
Mesalamine14$9,178
Breo ElliptaFluticasone/Vilanterol11$4,554
Arnuity ElliptaFluticasone Furoate11$2,992
Celecoxib86$2,499
LantusInsulin Glargine,hum.Rec.Anlog22$2,433
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$2,319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$677$76,14179 claims
PfizerEliquis$225$41,95839 claims
Lilly USA, LLCTrulicity, Mounjaro$772$39,97342 claims
Boehringer IngelheimJardiance$52$36,88230 claims
AstraZenecaFarxiga$173$18,76121 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$174$18,25740 claims
MerckJanuvia$70$15,75421 claims
Astellas Pharma US IncMyrbetriq$70$10,12823 claims
Sanofi-aventis U.S. LLCLantus$15$2,43322 claims
AbbVieSynthroid$251$2,14717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →